Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gilbert Harlan Daniels, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. M01RR001066 (SLAVIN, PETER L) Feb 1, 1978 - May 31, 2008
    NIH
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lubitz CC, Sadow PM, Daniels GH, Wirth LJ. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy. Thyroid. 2021 10; 31(10):1451-1462. PMID: 33860688; PMCID: PMC8591086.
    Citations: 4     Fields:    Translation:Humans
  2. Li JH, Daniels GH, Barbesino G. Painful Subacute Thyroiditis is Commonly Misdiagnosed as Suspicious Thyroid Nodular Disease. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5(2):330-337. PMID: 33997632; PMCID: PMC8105503.
    Citations: 1     
  3. Daniels GH, Li JH, Barbesino G. Imaging "Thyroiditis": A Primer for Radiologists. Curr Probl Diagn Radiol. 2021 Nov-Dec; 50(6):937-945. PMID: 33023768.
    Citations: 1     Fields:    Translation:Humans
  4. Verburg FA, Ahuja S, Avram AM, Bardiès M, Bernet V, Bourguet P, Führer-Sakel D, Draganescu C, Daniels GH, Greenspan B, Gulec S, Hegedüs L, Jonklaas J, Luster M, Oyen W, Smit J, Tuttle RM, Zerdoud S, Van Nostrand D. Brief progress report from the intersocietal working group on differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2020 06; 47(6):1345-1347. PMID: 32166513.
    Citations: 3     Fields:    Translation:Humans
  5. Daniels GH, Kopp PA. Guidelines Are Not Gospel! Thyroid. 2019 06; 29(6):753-757. PMID: 31044659; PMCID: PMC8881947.
    Citations:    Fields:    Translation:Humans
  6. Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Führer D, Giovanella L, Greenspan B, Luster M, Muylle K, Smit JWA, Van Nostrand D, Verburg FA, Hegedüs L. Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019 04; 29(4):461-470. PMID: 30900516.
    Citations: 69     Fields:    Translation:Humans
  7. Daniels GH. Follicular Thyroid Carcinoma: A Perspective. Thyroid. 2018 10; 28(10):1229-1242. PMID: 30039751.
    Citations: 13     Fields:    Translation:Humans
  8. Gopal RK, Kübler K, Calvo SE, Polak P, Livitz D, Rosebrock D, Sadow PM, Campbell B, Donovan SE, Amin S, Gigliotti BJ, Grabarek Z, Hess JM, Stewart C, Braunstein LZ, Arndt PF, Mordecai S, Shih AR, Chaves F, Zhan T, Lubitz CC, Kim J, Iafrate AJ, Wirth L, Parangi S, Leshchiner I, Daniels GH, Mootha VK, Dias-Santagata D, Getz G, McFadden DG. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. Cancer Cell. 2018 08 13; 34(2):242-255.e5. PMID: 30107175.
    Citations: 58     Fields:    Translation:Humans
  9. Hegedüs L, Sherman SI, Tuttle RM, von Scholten BJ, Rasmussen S, Karsbøl JD, Daniels GH. No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial. Diabetes Care. 2018 03; 41(3):620-622. PMID: 29279300.
    Citations: 12     Fields:    Translation:Humans
  10. Daniels GH. Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture? Thyroid. 2016 07; 26(7):872-4. PMID: 27214083.
    Citations: 10     Fields:    Translation:Humans
  11. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 07 28; 375(4):311-22. PMID: 27295427; PMCID: PMC4985288.
    Citations: 1581     Fields:    Translation:Humans
  12. Rothenberg SM, Daniels GH, Wirth LJ. Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-Response. Clin Cancer Res. 2015 Dec 15; 21(24):5640-1. PMID: 26672087.
    Citations: 16     Fields:    Translation:Humans
  13. Daniels GH, Hegedüs L, Marso SP, Nauck MA, Zinman B, Bergenstal RM, Mann JF, Derving Karsbøl J, Moses AC, Buse JB, Tuttle RM. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. Diabetes Obes Metab. 2015 May; 17(5):477-86. PMID: 25656058.
    Citations: 6     Fields:    Translation:Humans
  14. Daignault CP, Palmer EL, Scott JA, Swan JS, Daniels GH. Papillary Thyroid Carcinoma Metastasis to the Lumbar Spine Masquerading as a Schmorl's Node. Nucl Med Mol Imaging. 2015 Sep; 49(3):217-22. PMID: 26279695; PMCID: PMC4532686.
    Citations:    
  15. Rothenberg SM, McFadden DG, Palmer EL, Daniels GH, Wirth LJ. Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib. Clin Cancer Res. 2015 Mar 01; 21(5):1028-35. PMID: 25549723.
    Citations: 83     Fields:    Translation:Humans
  16. Steinberg WM, Nauck MA, Zinman B, Daniels GH, Bergenstal RM, Mann JF, Steen Ravn L, Moses AC, Stockner M, Baeres FM, Marso SP, Buse JB. LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. Pancreas. 2014 Nov; 43(8):1223-31. PMID: 25275271.
    Citations: 20     Fields:    Translation:Humans
  17. McFadden DG, Dias-Santagata D, Sadow PM, Lynch KD, Lubitz C, Donovan SE, Zheng Z, Le L, Iafrate AJ, Daniels GH. Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2014 Nov; 99(11):E2457-62. PMID: 25148236; PMCID: PMC4223441.
    Citations: 25     Fields:    Translation:Humans
  18. Pusztaszeri MP, Krane JF, Cibas ES, Daniels G, Faquin WC. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation. Cancer Cytopathol. 2014 Sep; 122(9):666-77. PMID: 24891128.
    Citations: 7     Fields:    Translation:Humans
  19. Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 2014 May 01; 120(9):1345-52. PMID: 24481684; PMCID: PMC3999178.
    Citations: 51     Fields:    Translation:Humans
  20. Daniels GH, Vladic A, Brinar V, Zavalishin I, Valente W, Oyuela P, Palmer J, Margolin DH, Hollenstein J. Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis. J Clin Endocrinol Metab. 2014 Jan; 99(1):80-9. PMID: 24170099.
    Citations: 50     Fields:    Translation:HumansCTClinical Trials
  21. Dhyani M, Faquin W, Lubitz CC, Daniels GH, Samir AE. How to interpret thyroid fine-needle aspiration biopsy reports: a guide for the busy radiologist in the era of the Bethesda Classification System. AJR Am J Roentgenol. 2013 Dec; 201(6):1335-9. PMID: 24261375.
    Citations: 3     Fields:    Translation:Humans
  22. Marso SP, Poulter NR, Nissen SE, Nauck MA, Zinman B, Daniels GH, Pocock S, Steinberg WM, Bergenstal RM, Mann JF, Ravn LS, Frandsen KB, Moses AC, Buse JB. Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. Am Heart J. 2013 Nov; 166(5):823-30.e5. PMID: 24176437.
    Citations: 76     Fields:    Translation:Humans
  23. Phitayakorn R, Morales-Garcia D, Wanderer J, Lubitz CC, Gaz RD, Stephen AE, Ehrenfeld JM, Daniels GH, Hodin RA, Parangi S. Surgery for Graves' disease: a 25-year perspective. Am J Surg. 2013 Nov; 206(5):669-73. PMID: 24011567.
    Citations: 5     Fields:    Translation:Humans
  24. Gunn AJ, Seethamraju RT, Hedgire S, Elmi A, Daniels GH, Harisinghani MG. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings. AJR Am J Roentgenol. 2013 Jul; 201(1):117-21. PMID: 23789664.
    Citations: 4     Fields:    Translation:Humans
  25. Daniels GH, Sluss P. Pure T3-thyrotoxicosis from a Mexican weight loss supplement. Endocr Pract. 2013 May-Jun; 19(3):559-60. PMID: 23425657.
    Citations: 2     Fields:    Translation:Humans
  26. Daniels GH. What is the role of molecular markers in the management of "indeterminate" thyroid nodules? Cancer Cytopathol. 2013 May; 121(5):223-4. PMID: 23670834.
    Citations: 3     Fields:    Translation:Humans
  27. Daniels GH. Radioactive iodine: a slice of history. Thyroid. 2013 Mar; 23(3):253-8. PMID: 23121056.
    Citations: 2     Fields:    Translation:Humans
  28. Prescott JD, Sadow PM, Hodin RA, Le LP, Gaz RD, Randolph GW, Stephen AE, Parangi S, Daniels GH, Lubitz CC. BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery. 2012 Dec; 152(6):984-90. PMID: 23158172; PMCID: PMC3502879.
    Citations: 26     Fields:    Translation:Humans
  29. Nagarkatti SS, Faquin WC, Lubitz CC, Garcia DM, Barbesino G, Ross DS, Hodin RA, Daniels GH, Parangi S. Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy. Ann Surg Oncol. 2013 Jan; 20(1):60-5. PMID: 22941160.
    Citations: 18     Fields:    Translation:Humans
  30. Cronin CG, Prakash P, Daniels GH, Boland GW, Kalra MK, Halpern EF, Palmer EL, Blake MA. Brown fat at PET/CT: correlation with patient characteristics. Radiology. 2012 Jun; 263(3):836-42. PMID: 22623697.
    Citations: 21     Fields:    Translation:Humans
  31. Lubitz CC, Nagarkatti SS, Faquin WC, Samir AE, Hassan MC, Barbesino G, Ross DS, Randolph GW, Gaz RD, Stephen AE, Hodin RA, Daniels GH, Parangi S. Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy. Thyroid. 2012 Jun; 22(6):590-4. PMID: 22667452.
    Citations: 13     Fields:    Translation:Humans
  32. Barbesino G, Goldfarb M, Parangi S, Yang J, Ross DS, Daniels GH. Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up. Thyroid. 2012 Apr; 22(4):369-76. PMID: 22385290.
    Citations: 6     Fields:    Translation:Humans
  33. Samir AE, Vij A, Seale MK, Desai G, Halpern E, Faquin WC, Parangi S, Hahn PF, Daniels GH. Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate. Thyroid. 2012 May; 22(5):461-7. PMID: 22304390.
    Citations: 42     Fields:    Translation:Humans
  34. Stathatos N, Daniels GH. Autoimmune thyroid disease. Curr Opin Rheumatol. 2012 Jan; 24(1):70-5. PMID: 22157414.
    Citations: 21     Fields:    Translation:Humans
  35. Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Moore FD, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery. 2011 Dec; 150(6):1168-77. PMID: 22136837; PMCID: PMC3880195.
    Citations: 14     Fields:    Translation:Humans
  36. Daniels GH. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada. Thyroid. 2011 Nov; 21(11):1199-207. PMID: 21936671.
    Citations: 12     Fields:    Translation:Humans
  37. Daniels GH. What if many follicular variant papillary thyroid carcinomas are not malignant? A review of follicular variant papillary thyroid carcinoma and a proposal for a new classification. Endocr Pract. 2011 Sep-Oct; 17(5):768-87. PMID: 21940284.
    Citations: 10     Fields:    Translation:Humans
  38. Daniels GH. The American Thyroid Association and American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: an appraisal. Endocr Pract. 2011 May-Jun; 17(3):325-33. PMID: 21700559.
    Citations: 4     Fields:    Translation:Humans
  39. Calvi L, Daniels GH. Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye. Thyroid. 2011 Apr; 21(4):443-9. PMID: 21385076.
    Citations: 5     Fields:    Translation:Humans
  40. Stathatos N, Gaz R, Ross DS, Daniels GH. High radioactive iodine uptake despite a fully suppressed TSH in a patient with thyroid cancer. J Clin Endocrinol Metab. 2011 Mar; 96(3):589. PMID: 21378221.
    Citations:    Fields:    Translation:Humans
  41. Hegedüs L, Moses AC, Zdravkovic M, Le Thi T, Daniels GH. GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. J Clin Endocrinol Metab. 2011 Mar; 96(3):853-60. PMID: 21209033.
    Citations: 60     Fields:    Translation:Humans
  42. Tuttle RM, Ball DW, Byrd D, Daniels GH, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ. Medullary carcinoma. J Natl Compr Canc Netw. 2010 May; 8(5):512-30. PMID: 20495082.
    Citations: 24     Fields:    Translation:Humans
  43. Daniels GH. Response to 'How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement?'. Clin Endocrinol (Oxf). 2009 Oct; 71(4):603; author reply 603-4. PMID: 19473176.
    Citations:    Fields:    Translation:Humans
  44. Daniels GH. Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al. Clin Endocrinol (Oxf). 2009 Sep; 71(3):455. PMID: 19138312.
    Citations:    Fields:    Translation:Humans
  45. Lawson EA, Buchbinder BR, Daniels GH. Hypopituitarism associated with a giant aneurysm of the internal carotid artery. J Clin Endocrinol Metab. 2008 Dec; 93(12):4616. PMID: 19056841.
    Citations: 5     Fields:    Translation:Humans
  46. Daniels GH. Article misquote in "Multiple endocrinopathies associated with lithium therapy". Endocr Pract. 2008 Mar; 14(2):253. PMID: 18309582.
    Citations:    Fields:    Translation:Humans
  47. Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS, Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ. A phase II study of gefitinib in patients with advanced thyroid cancer. Thyroid. 2008 Mar; 18(3):317-23. PMID: 17985985.
    Citations: 70     Fields:    Translation:HumansCTClinical Trials
  48. Faris JE, Moore AF, Daniels GH. Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report. Thyroid. 2007 Nov; 17(11):1147-9. PMID: 17714037.
    Citations: 9     Fields:    Translation:Humans
  49. Sherman SI, Angelos P, Ball DW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Ridge JA, Shah JP, Sisson JC, Tuttle RM, Urist MM. Thyroid carcinoma. J Natl Compr Canc Netw. 2007 Jul; 5(6):568-621. PMID: 17623612.
    Citations: 21     Fields:    Translation:Humans
  50. Herraiz M, Barbesino G, Faquin W, Chan-Smutko G, Patel D, Shannon KM, Daniels GH, Chung DC. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):367-73. PMID: 17258512.
    Citations: 26     Fields:    Translation:HumansPHPublic Health
  51. Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, Cooper DS, Schuff KG, Braverman LE, Skarulis MC, Davies TF, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Weintraub BD, Ridgway EC, Ladenson PW. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab. 2006 Mar; 91(3):878-84. PMID: 16394083.
    Citations: 47     Fields:    Translation:HumansCTClinical Trials
  52. Goggins W, Daniels GH, Tsao H. Elevation of thyroid cancer risk among cutaneous melanoma survivors. Int J Cancer. 2006 Jan 01; 118(1):185-8. PMID: 16049985.
    Citations: 10     Fields:    Translation:Humans
  53. Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Clin Endocrinol (Oxf). 2005 Dec; 63(6):676-82. PMID: 16343103.
    Citations: 7     Fields:    Translation:Humans
  54. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005 Sep; 90(9):5489-96. PMID: 16148346.
    Citations: 52     Fields:    Translation:Humans
  55. Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Ridge JA, Robbins R, Shah JP, Sisson JC, Thompson NW. Thyroid carcinoma. J Natl Compr Canc Netw. 2005 May; 3(3):404-57. PMID: 16002006.
    Citations: 15     Fields:    Translation:Humans
  56. Col NF, Surks MI, Daniels GH. Subclinical thyroid disease: clinical applications. JAMA. 2004 Jan 14; 291(2):239-43. PMID: 14722151.
    Citations: 27     Fields:    Translation:Humans
  57. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14; 291(2):228-38. PMID: 14722150.
    Citations: 370     Fields:    Translation:HumansPHPublic Health
  58. Kim BW, Daniels GH, Harrison BJ, Price A, Harney JW, Larsen PR, Weetman AP. Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab. 2003 Feb; 88(2):594-8. PMID: 12574186.
    Citations: 19     Fields:    Translation:Humans
  59. Randolph GW, Daniels GH. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid. 2002 Nov; 12(11):989-96. PMID: 12490076.
    Citations: 7     Fields:    Translation:Humans
  60. Daniels GH. Evidence-based medicine: common sense discarded. Endocr Pract. 2002 Sep-Oct; 8(5):389. PMID: 15259118.
    Citations:    Fields:    Translation:Humans
  61. Wunderbaldinger P, Harisinghani MG, Hahn PF, Daniels GH, Turetschek K, Simeone J, O'Neill MJ, Mueller PR. Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol. 2002 Mar; 178(3):693-7. PMID: 11856700.
    Citations: 12     Fields:    Translation:Humans
  62. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf). 2001 Oct; 55(4):501-8. PMID: 11678833.
    Citations: 14     Fields:    Translation:Humans
  63. Daniels GH. Atypical subacute thyroiditis: preliminary observations. Thyroid. 2001 Jul; 11(7):691-5. PMID: 11484899.
    Citations: 6     Fields:    Translation:Humans
  64. Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2001 Jan; 86(1):3-8. PMID: 11231968.
    Citations: 22     Fields:    Translation:HumansAnimals
  65. Kearns AE, Goff DC, Hayden DL, Daniels GH. Risperidone-associated hyperprolactinemia. Endocr Pract. 2000 Nov-Dec; 6(6):425-9. PMID: 11155212.
    Citations: 11     Fields:    Translation:Humans
  66. Daniels GH. Hyperthyroidism: multiple possibilities in the female patient. Int J Fertil Womens Med. 1999 Jan-Feb; 44(1):6-11. PMID: 10206194.
    Citations:    Fields:    Translation:Humans
  67. Seminara SB, Daniels GH. Amiodarone and the thyroid. Endocr Pract. 1998 Jan-Feb; 4(1):48-57. PMID: 15251765.
    Citations: 3     Fields:    
  68. Centeno BA, Szyfelbein WM, Daniels GH, Vickery AL. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls. Acta Cytol. 1996 Nov-Dec; 40(6):1189-97. PMID: 8960027.
    Citations: 4     Fields:    Translation:Humans
  69. Daniels GH. Thyroid nodules and nodular thyroids: a clinical overview. Compr Ther. 1996 Apr; 22(4):239-50. PMID: 8733781.
    Citations: 5     Fields:    Translation:Humans
  70. Hsu SI, Thadhani RI, Daniels GH. Acute compartment syndrome in a hypothyroid patient. Thyroid. 1995 Aug; 5(4):305-8. PMID: 7488873.
    Citations: 7     Fields:    Translation:Humans
  71. Randolph GW, Fabian RL, Daniels GH. Perithyroid Teflon granuloma mimicking a thyroid nodule. Otolaryngol Head Neck Surg. 1995 Mar; 112(3):465-8. PMID: 7870452.
    Citations:    Fields:    Translation:Humans
  72. Grinspoon SK, Daniels GH. Case report: increased levothyroxine requirement in a patient with cryptic celiac-sprue disease. Endocr Pract. 1995 Mar-Apr; 1(2):88-90. PMID: 15251601.
    Citations:    Fields:    
  73. Lee MJ, Ross DS, Mueller PR, Daniels GH, Dawson SL, Simeone JF. Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis. Radiology. 1993 Jun; 187(3):851-4. PMID: 8497644.
    Citations: 4     Fields:    Translation:Humans
  74. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol. 1992 Jan; 147(1):1-10. PMID: 1729490.
    Citations: 93     Fields:    Translation:Humans
  75. Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab. 1990 Sep; 71(3):764-9. PMID: 2394778.
    Citations: 25     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Daniels's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (259)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.